Escitalopram for Older Adults With Generalized Anxiety Disorder | Zendy

Eric J. Lenze | Zendy; Bruce L. Rollman | Zendy; M. Katherine Shear | Zendy; Mary Amanda Dew | Zendy; Bruce G. Pollock | Zendy; Caroline M. Ciliberti | Zendy; Michelle Costantino | Zendy; Sara A. Snyder | Zendy; Peichang Shi | Zendy; Edward L. Spitznagel | Zendy; Carmen Andreescu | Zendy; Meryl A. Butters | Zendy; Charles F. Reynolds | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Escitalopram for Older Adults With Generalized Anxiety Disorder

Author(s) -

Eric J. Lenze,

Bruce L. Rollman,

M. Katherine Shear,

Mary Amanda Dew,

Bruce G. Pollock,

Caroline M. Ciliberti,

Michelle Costantino,

Sara A. Snyder,

Peichang Shi,

Edward L. Spitznagel,

Carmen Andreescu,

Meryl A. Butters,

Charles F. Reynolds

Publication year - 2009

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2008.977

Subject(s) - escitalopram , medicine , placebo , psychiatry , generalized anxiety disorder , anxiety , sertraline , randomized controlled trial , tolerability , adverse effect , antidepressant , alternative medicine , pathology

Generalized anxiety disorder (GAD) is one of the most common psychiatric disorders in older adults; however, few data exist to guide clinicians in efficacious and safe treatment. Selective serotonin reuptake inhibitors (SSRIs) are efficacious for younger adults with GAD, but benefits and risks may be different in older adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research